Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Gastrointestinal 1

Conditions

Neoplasms 7Stomach Neoplasms 4Malnutrition 4Breast Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Biliary Tract Neoplasms 2Surgery--Complications 1Peptic Ulcer 1Nasopharyngeal Carcinoma 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Malabsorption Syndromes 1Lymphoma 1Lung Neoplasms 1Locally Advanced Head and Neck Carcinoma 1Liver Neoplasms 1Inflammatory Bowel Diseases 1Infections 1Hyperphagia 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Esophagitis 1Duodenal Neoplasms 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × Dietary Supplements × Clear all
NCT07199556 2025-10-03

DOLFLEX

Arafarma Group, S.A.

Phase NA Completed
30 enrolled
Breast

Breast Neoplasms

NCT07021378 2025-06-15

NESTLE

D'Or Institute for Research and Education

Phase NA Completed
16 enrolled
BreastGastrointestinal

Anus Neoplasms, Breast Neoplasms, Malnutrition

NCT06214598 2024-05-09

AID

University of Belgrade

Phase NA Recruiting
90 enrolled
Breast

Breast Neoplasms

NCT05762042 2023-03-09

Comparison of the Efficacy and Tolerability of Femal Versus Placebo

Azienda Ospedaliera Ordine Mauriziano di Torino

Phase NA Completed
34 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡